Targeting of the EMT effector transcription factors, including Snail, Slug, Twist, and Zeb1/2, has been recognized as a potential therapeutic strategy in breast cancer cells [116] and non-small cell lung cancer, [117] where targeted inactivation of Snail family suppressed tumor cell proliferation and metastasis. This evidence concerns the gene SNAI2 and breast carcinoma.